Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Metformin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 8 Leukoplakia, Oral 2 Breast Neoplasms 2 Weight Loss 1 Urothelial Cancer 1 TP53 Y220C Mutation 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Posterior Fossa Ependymal Tumor 1 Pancreatic Adenocarcinoma 1 Mouth Neoplasms 1 Monoclonal Gammopathy of Undetermined Significance 1 Metabolic Syndrome 1 Metabolic Diseases 1 Medulloblastoma 1 Insulin Resistance 1 Infertility, Female 1 Infertility 1 Hyperplasia 1 Erythroplasia 1 Cognitive Dysfunction 1 Castration Sensitive Prostate Cancer 1 Carcinoma, Intraductal, Noninfiltrating 1 Anatomic Stage I Breast Cancer AJCC v8 1 Advanced Solid Malignancies 1

Interventions

Oxaliplatin 15 Capecitabine 14 Fluorouracil 13 Leucovorin 9 Radiotherapy 8 Cetuximab 8 Bevacizumab 7 pembrolizumab 6 Nivolumab 6 Irinotecan 5 Chemoradiotherapy 5 Drug Therapy 4 Surveys and Questionnaires 3 Specimen Handling 3 Radiotherapy, Intensity-Modulated 3 Pemetrexed 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Folfox protocol 3 Cisplatin 3 Carboplatin 3 trifluridine tipiracil drug combination 2 tislelizumab 2 dostarlimab 2 X-Rays 2 Trastuzumab 2 Sigmoidoscopy 2 Radiation 2 Paclitaxel 2 Neoadjuvant Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02437656 2026-03-16

METCAP

Centre Oscar Lambret

Phase 2 Completed

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡